Evidence map›Paper›PMID 41395849›Full record

ReviewJournal of cosmetic dermatology2025

Visual Aesthetics (VA) Methodology: A Strategic Approach to Facial Rejuvenation.

Vorapot Siramangkhalanon

Abstract readCase ReportsReview
In one paragraph

Review in Journal of cosmetic dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Vorapot SiramangkhalanonHertitude Clinic, Bangkok, Thailand.ORCID https://orcid.org/0009-0002-9751-697X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe demand for natural, harmonized facial rejuvenation has shifted aesthetics practice from localized correction toward comprehensive full-face strategies. However, many current injection techniques remain region-based, leading to inconsistent results and limited reproducibility. Reliable and reproducible methodologies are essential for delivering outcomes that align with patient expectations and broader aesthetic ideals.

objectiveTo introduce the Visual Aesthetics (VA) methodology, a structured, patient-centered framework designed to enhance standardization, safety, and clinical outcomes in injectable facial rejuvenation.

methodsVA methodology is built on four sequential pillars across the patient journey: (1) Communication-eliciting true patient insight beyond stated complaints; (2) Analysis-applying Visual Impact Analysis (VIA) to assess proportion, framework, sagginess, and projection; (3) Planning-sequencing treatment via vector aesthetics (lifting → projection → volume optimization → detail enhancement); and (4) Execution-performing anatomy-based targeted injections (TIs) codified with seven parameters for enhanced reproducibility and safety. Two illustrative cases (31- and 60-year-old Thai females) demonstrated its clinical application and outcome durability of this methodology.

resultsSustained aesthetic improvement was observed at 24 and 27 months in the two illustrative cases, including enhanced midface support, chin projection, and correction of tear troughs or jowl sagging. Patients reported high satisfaction. No major complications were encountered when safety protocols were followed, including adherence to vascular alert mapping and preparedness to administer hyaluronidase in the event of vascular compromise.

conclusionVA methodology provides a reproducible and holistic framework that integrates anatomical precision with individualized goals. Further multicenter studies are warranted to validate long-term outcomes and to explore their applicability across diverse clinical and cultural settings.

Indexed as

Cosmetic TechniquesDermal FillersRejuvenationSkin AgingAdultEstheticsFaceFemaleHumansMiddle AgedPatient SatisfactionReproducibility of ResultsTreatment OutcomeDermal Fillersdermal fillersfacial rejuvenationinjection safetytreatment sequencingVA methodologyvisual impact analysis

Identifiers

PMID41395849
PMCPMC12704028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.